Karmen, A.; Wróblewski, F.; and LaDue, J. S.: Transaminase Activity in Human Blood , J. Clin. Invest. 34:126-133 (
(Jan.)
) 1955;.
Wróblewski, F., and LaDue, J. S.: Lactic Dehydrogenase Activity in Blood , Proc. Soc. Exper. Biol. & Med. 90: 210-213 (
(Oct.)
) 1955;.
Wróblewski, F.; Ruegsegger, P., and LaDue, J. S.: Serum Lactic Dehydrogenase Activity in Acute Transmural Myocardial Infarction , Science 123:1122-1123 (
(June 22)
) 1956;.
Hill, B. R., and Levi, C.: Elevation of Serum Component in Neoplastic Disease , Cancer Res. 14:513-515 (
(Aug.)
) 1954;.
Hsieh, K. M., and Blumenthal, H. T.: Serum Lactic Dehydrogenase Levels in Various Disease States , Proc. Soc. Exper. Biol. & Med. 91:626-630 (
(April)
) 1956;.
White, L. P.: Serum Enzymes: Serum Lactic Dehydrogenase in Myocardial Infarction , New England J. Med. 255:984-988 (
(Nov. 22)
) 1956;.
Wacker, W. E. C.; Ulmer, D. D.; and Vallee, B. L.: Malic and Lactic Dehydrogenase Activities and Zinc Concentrations in Serum , New England J. Med. 255:449-456 (
(Sept. 6)
) 1956;.
Hsieh, K. M.; Suntzeff, V.; and Cowdry, E. V.: Serum Lactic Dehydrogenase Activity as Indication of Neoplastic Growth and Regression , Proc. Soc. Exper. Biol. & Med. 89:627-629 (
(Aug.)
) 1955;
Comparative Study of Serum Lactic Dehydrogenase Activity in Mice with Transplanted and Induced Tumors , Cancer Res. 16:237-239 (
(March)
) 1956;.
Zimmerman, H. J.; West, M.; and Weinstein, H. G.: Serum Lactic Dehydrogenase and Glutamic Oxaloacetic Transaminase Levels in Disease , abstracted, Proc. Central Soc. Clin. Res. 29:100, 1956;.
Ostrow, B. H., and others: Serum Glutamic-Oxaloacetic Transaminase in Coronary Artery Disease: Review of 201 Cases , Circulation 14:790-799 (
(Nov.)
) 1956;.
LaDue, J. S.; Wróblewski, F.; and Karmen, A.: Serum Glutamic Oxaloacetic Transaminase Activity in Human Acute Transmural Myocardial Infarction , Science 120:497-499 (
(Sept. 24)
) 1954;.
Chinsky, M.; Shmagranoff, G. L.; and Sherry, S.: Serum Transaminase Activity: Observations in Large Group of Patients , J. Lab. & Clin. Med. 47:108-118 (
(Jan.)
) 1956;.
Volk, B. W.; Losner, S.; Aronson, S. M.; and Lew, H.: Serum Aldolase Level in Acute Myocardial Infarction , Am. J. M. Sc. 232:38-43 (
(July)
) 1956;.
Wróblewski, F.; Jervis, G.; and LaDue, J. S.: Diagnostic, Prognostic and Epidemiologic Significance of Serum Glutamic Oxaloacetic Transaminase (SGO-T ) Alterations in Acute Hepatitis , Ann. Int. Med. 45:782-800 (
(Nov.)
) 1956;.
Wróblewski, F.; and LaDue, J. S.: Serum Glutamic Pyruvic Transaminase in Hepatic Disease: Preliminary Report , Ann. Int. Med. 45:801-811 (
(Nov.)
) 1956;.
Sibley, J. A., and Fleisher, G. A.: Clinical Significance of Serum Aldolase , Proc. Staff Meet. Mayo Clin. 29:591-603 (
(Nov. 10)
) 1954;.
Footnotes 2b, 3, and 4a and f.
Footnotes 3 and 4d and e.